Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cholangiolar carcinoma]

P N Meier1, M P Manns

  • 1Abteilung Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover.

Leber, Magen, Darm
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Cholangiocarcinoma, a bile duct cancer, often presents in those aged 50-70 and is linked to conditions like primary sclerosing cholangitis. Diagnosis involves imaging and tumor markers, with poor prognosis despite treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virological and clinical characteristics of delta hepatitis in Central Europe.

Journal of viral hepatitis·2009
Same author

Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.

Vaccine·2009
Same author

Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

Zeitschrift fur Gastroenterologie·2009
Same author

[Liver transplantation: indications and results].

Der Internist·2009
Same author

[Transplantation medicine 2009].

Der Internist·2009
Same author

Transient autoimmune hepatitis induced by a thymoma.

The American journal of gastroenterology·2009
Same journal

[Cost savings with preoperative ambulatory diagnosis in elective gastrointestinal operations].

Leber, Magen, Darm·1996
Same journal

[Pseudo-esophagitis in antacid abuse].

Leber, Magen, Darm·1996
Same journal

[Aortoduodenal fistula as the cause of gastrointestinal hemorrhage].

Leber, Magen, Darm·1996
Same journal

[Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity--a pilot study].

Leber, Magen, Darm·1996
Same journal

[Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases. Working Group of the German Society of Digestive and Metabolic Diseases].

Leber, Magen, Darm·1996
Same journal

[Diagnosis and therapy of portal hypertension].

Leber, Magen, Darm·1996
See all related articles

Area of Science:

  • Gastroenterology and Hepatology
  • Oncology
  • Medical Diagnostics

Context:

  • Cholangiocarcinoma (bile duct cancer) affects individuals aged 50-70, with known associations to primary sclerosing cholangitis, ulcerative colitis, and parasitic infections.
  • Approximately 95% of cholangiocarcinomas are histopathologically classified as adenocarcinomas.
  • Tumor location significantly influences clinical presentation, with hilar tumors typically causing obstructive jaundice.

Purpose:

  • To review the epidemiology, clinical presentation, diagnostic methods, and treatment strategies for cholangiocarcinoma.
  • To highlight the diagnostic importance of imaging (ultrasonography, cholangiography) and tumor markers (CEA, CA 19-9).
  • To discuss current treatment options including resection and palliative decompression, and to emphasize the generally poor prognosis.

Related Experiment Videos

Summary:

  • Cholangiocarcinoma is a prevalent adenocarcinoma in individuals aged 50-70, associated with specific diseases and parasitic infections.
  • Clinical manifestations vary by tumor location, with obstructive jaundice being characteristic of hilar tumors. Diagnostic tools include imaging, tumor markers (CEA, CA 19-9), and cytology.
  • Treatment focuses on resection or palliative stenting for jaundice relief, as chemotherapy and transplantation offer limited success. The overall prognosis remains poor.

Impact:

  • Improved understanding of cholangiocarcinoma's diverse clinical presentations based on tumor location.
  • Enhanced awareness of key diagnostic markers and imaging techniques for early detection and staging.
  • Highlights the limitations of current systemic therapies and the need for novel treatment approaches for bile duct cancer.